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Prokaryotic CRISPR-Cas adaptive immune systems insert spacers derived from 23	  
viruses and other parasitic DNA elements into CRISPR loci to provide sequence-24	  
specific immunity1,2. This frequently results in high within-population spacer 25	  
diversity3-6, but it is unclear if and why this is important. Here, we show that as a 26	  
result of this spacer diversity, viruses can no longer evolve to overcome CRISPR-27	  
Cas by point mutation, which results in rapid virus extinction. This effect arises 28	  
from synergy between spacer diversity and the high specificity of infection, 29	  
which greatly increases overall population resistance. We propose that the 30	  
resulting short-lived nature of CRISPR-dependent bacteria-virus coevolution 31	  
has provided strong selection for the evolution of sophisticated virus-encoded 32	  
anti-CRISPR mechanisms7. 33	  
 34	  
We previously reported that Pseudomonas aeruginosa strain UCBPP-PA14 evolves 35	  
high levels of CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic 36	  
Repeats; CRISPR-associated) adaptive immunity against virus DMS3vir under 37	  
laboratory conditions6. However, viruses can readily evolve to overcome sequence 38	  
specific CRISPR immunity8,9. To study how CRISPR-Cas impacts virus persistence, 39	  
we measured titers of virus DMS3vir over time upon infection of either wild type 40	  
(WT) P. aeruginosa or a functional CRISPR-Cas knock-out (CRISPR KO) strain. 41	  
Virus that infected the WT strain went extinct at 5 days post-infection (dpi) (Fig. 1A), 42	  
whereas virus infecting the CRISPR KO strain persisted in all replicates until the 43	  
experiment was terminated at 30 dpi (Fig. 1B). WT bacteria exclusively evolved 44	  
CRISPR-mediated immunity, while the CRISPR KO strain evolved immunity by 45	  
mutation, loss or masking of the receptor (i.e. surface mutation) (Extended Data Fig. 46	  
1A). The observation that CRISPR-Cas drives virus extinct so rapidly was unexpected 47	  
since viruses can escape CRISPR immunity by a single point mutation8,9. 48	  
Virus extinction might result from the high level of spacer diversity that 49	  
naturally evolves upon virus exposure in this and other CRISPR-Cas systems3-6. Both 50	  
theory and data suggest that host genetic diversity can synergistically reduce the 51	  
spread of parasites if the infection process is specific (i.e. a parasite genotype can 52	  
infect a restricted number of host genotypes) and a failed infection results in parasite 53	  
death10-18; assumptions that hold for CRISPR-Cas-virus interactions. While the 54	  
protective effect of host diversity may be lost following the evolution of single viruses 55	  
that escape from multiple spacers10,17, host diversity has the additional benefit of 56	  
limiting such viral adaptation. Specifically, lower virus population sizes resulting 57	  
from host diversity11,12 reduces the probability of escape mutations, and the greater 58	  
the diversity the more escape mutations needed.  59	  
To examine these hypotheses, we generated bacterial populations in which we 60	  
manipulated the level of spacer diversity; we used 48 individual clones with CRISPR-61	  
based immunity against virus DMS3vir to generate bacterial populations with five 62	  
distinct diversity levels: monocultures or polycultures consisting of equal mixtures of 63	  
either 6, 12, 24 or 48 clones. To allow for direct comparisons, each of the 48 clones 64	  
was equally represented at each diversity level by adjusting the number of replicate 65	  
experiments accordingly. Each population was competed against a previously 66	  
described surface mutant6 in the presence or absence of virus DMS3vir and virus 67	  
levels were monitored over time. 68	  
This experiment revealed a strong inverse relationship between virus 69	  
persistence and the level of spacer diversity in the bacterial population (Fig. 2). Virus 70	  
titers remained high in 44 out of 48 replicates when the CRISPR population consisted 71	  
of a monoculture (Fig. 2A). However, as diversity increased, virus persistence 72	  
decreased (Fig. 2B-E) and virus was driven extinct rapidly and reproducibly when the 73	  
CRISPR population consisted of a 48-clone mixture (Fig. 2E). 74	  
Next, we examined the fitness consequences of generating spacer diversity. In 75	  
the absence of virus there was no significant effect of diversity on the relative fitness 76	  
associated with CRISPR-Cas compared to a resistant surface mutant (Extended Data 77	  
Fig. 1B; F1, 52=3.20, p=0.08). However, in the presence of virus CRISPR-associated 78	  
fitness increased with increasing spacer diversity (Fig. 3; F4,71=40.30 p<0.0001 and 79	  
Extended Data Table 1), with mean fitness increasing 11-fold from monoculture to 80	  
the highest diversity population. In monoculture, the CRISPR population was 81	  
outcompeted by the surface mutant (rel. fitness < 1 ; T=-11.68, p<0.0001). However, 82	  
as diversity increased, the CRISPR population consistently outcompeted the surface 83	  
mutant (rel. fitness > 1; 6-clones: T=3.05, p=0.0093; 12-clones: T=3.95, p=0.0028; 84	  
24-clones: T=3.48, p=0.0088; 48-clones: T=3.06, p=0.014; all significant after 85	  
sequential Bonferroni correction19), showing that the generation of spacer diversity is 86	  
an important fitness determinant of CRISPR-Cas (Fig. 3).  87	  
Given that all bacterial clones used in the experiment were initially resistant, 88	  
we hypothesized that the benefit of spacer diversity emerges from an inability of virus 89	  
to evolve escape mutants. To examine this, virus isolated from each time point (0, 16, 90	  
24, 40, 48, 64 and 72 hours post-infection) was spotted onto lawns of each of the 48 91	  
CRISPR clones. As expected, we could not detect escape virus in the ancestral virus 92	  
(Fig. 4A; left column, indicated in green). However, in 43 of the 48 CRISPR 93	  
monocultures, virus evolved within 2 days to overcome CRISPR immunity (Fig. 4A; 94	  
indicated in red). For 5 clones no escape virus could be detected, and virus went 95	  
extinct in 4 of these instances (Fig. 4A, asterisks). Three of these 5 clones carried 96	  
multiple spacers targeting the virus, which limits the emergence of escape virus16. The 97	  
emergence of escape virus decreased as diversity increased to 6, 12, 24 and 48 98	  
CRISPR alleles (Fig. 4); in the latter two, no escape virus could be detected. These 99	  
phenotypic data were supported by results of deep sequencing of virus genotypes 100	  
isolated from 1 dpi: there was a significant inverse relationship between host diversity 101	  
and the accumulation of viral mutations in the target sequences (Extended Data Figs. 102	  
1CD). This is because virus needs to overcome multiple spacers in the diverse host 103	  
population if it is to increase in frequency (Extended Data Fig. 1EF). Consistent with 104	  
a lack of escape virus emerging against all host genotypes, the spacer content of 105	  
mixed populations of 6, 12, 24 and 48 clones did not increase between t=0 and t=3 106	  
(Wilcoxon Signed Rank p>0.2 for all treatments), whereas monocultures acquired 107	  
novel spacers in response to emerging escape virus (Wilcoxon Signed Rank W=333, 108	  
DF=47, p<0.0001; Extended Data Fig. 1G). These data show that while escape 109	  
viruses can clearly evolve against most of the clones, escape viruses do not emerge 110	  
when these clones are mixed.  111	  
 We hypothesized that the benefit of within-population spacer diversity is 112	  
because of synergy between the different clones. However, diversity will also increase 113	  
the chance that the population will contain a single clone with one or more spacers 114	  
that the virus is unable to overcome. Indeed, we observed 5 clones against which 115	  
escape mutants were never detected, and presence of these clones in many of the 116	  
diverse populations could explain the fitness advantage of diversity. To investigate if 117	  
synergy plays an important role in the benefit of diversity beyond this “jackpot” 118	  
effect, we compared the fitness of diverse populations with the fitness of the fittest 119	  
constituent clone, as measured in monoculture. This analysis revealed that synergism 120	  
contributed an approximately 50% growth rate advantage when in competition with 121	  
surface mutants (mean ± SEM difference in fitness between mixtures and fittest 122	  
constituent monoculture = 0.47 ± 0.18; P < 0.01). 123	  
The short-lived nature of coevolution between CRISPR-resistant bacteria and 124	  
virus escape mutants beyond a host diversity threshold may explain the evolution of 125	  
sophisticated anti-CRISPR mechanisms to overcome CRISPR-Cas7. Indeed, a virus 126	  
carrying an anti-CRISPR gene7 was found to persist independent of CRISPR diversity 127	  
levels (Extended Data Fig. 1HI) and caused similar extinction of CRISPR-resistant 128	  
monocultures and 48-clone populations that competed against a surface mutant 129	  
(Fisher’s exact test, p=1.0 at t=1, p=0.33 at t=3 dpi; Extended Data Fig. 1J). 130	  
Finally, to test that our results were not limited to the P. aeruginosa PA14 131	  
Type I-F CRISPR-Cas system, we performed a similar experiment with Streptococcus 132	  
thermophilus DGCC7710 clones that evolved resistance against virus 2972 using a 133	  
Type II-A CRISPR-Cas system. As shown in Extended Data Fig. 2, we found a 134	  
similar effect of CRISPR resistance allele diversity on virus persistence and escape 135	  
virus emergence. However, during coevolution experiments the levels of evolved 136	  
spacer diversity are lower in S. thermophilus (data not shown and refs. 4,5), which, 137	  
consistent with theory10,17, allows for more persistent coevolution4,5. Lower levels of 138	  
evolved spacer diversity might be due to a more weakly primed CRISPR-Cas 139	  
system20-22. 140	  
Collectively, our data demonstrate that the propensity to generate host genetic 141	  
diversity is a key fitness determinant of CRISPR-Cas adaptive immune systems 142	  
because it limits the emergence of escape virus. Consistent with the idea that it is 143	  
harder for a parasite to adapt to a heterogeneous host population23, virus rapidly 144	  
evolved high levels of infectivity on monocultures, but not on a diverse mix of the 145	  
same host genotypes. Parasites are often invoked as the selective force driving the 146	  
evolution of diversity generating mechanisms23-26. In most cases, individual-level 147	  
selection is assumed to be the driver of these traits, because individual benefits are 148	  
high, and group selective benefits would be opposed by the invasion of individuals 149	  
who do not pay the fitness costs associated with these mechanisms (e.g. sex and 150	  
increased mutation rates)26-28. In the case of CRISPR-Cas, we speculate that 151	  
population-level selection may have contributed to its evolution. First, there were 152	  
large benefits associated with synergy between diverse genotypes. Second, costs of 153	  
CRISPR-Cas are conditional on virus exposure6,29 and clones lacking CRISPR 154	  
immunity cannot invade populations (Extended Data Figs. 3 and 4). Third, the highly 155	  
structured nature of bacterial populations, and the resulting high relatedness, promotes 156	  
between-population selection30. Future tests of this hypothesis are needed to reconcile 157	  
the selective forces that have shaped the evolution of CRISPR-Cas systems.  158	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Figure legends 263	  
Figure 1. Evolution of CRISPR-mediated immunity leads to rapid extinction of 264	  
virus.  265	  
Titer (pfu/ml) of virus DMS3vir over time upon infection of A) WT P. aeruginosa 266	  
and B) P. aeruginosa strain csy3::LacZ (CRISPR KO strain). Each line indicates a 267	  
biological replicate experiment (n=6). The limit of detection is 200 pfu/ml. 268	  
 269	  
Figure 2. Virus persistence inversely correlates with the level of spacer diversity.  270	  
Virus titers (pfu/ml) over time upon infection of a bacterial population consisting of 271	  
an equal mixture of a surface mutant and A) a monoculture with CRISPR-mediated 272	  
immunity (n=48), or polycultures with CRISPR-mediated immunity consisting of B) 273	  
6 clones (n=8), C) 12 clones (n=8), D) 24 clones (n=6), E) 48 clones (n=6). The 274	  
number of replicates is chosen such that all clones are equally represented in each 275	  
treatment. Each line indicates a biological replicate experiment; in all cases n is the 276	  
number of biological replicates. The limit of detection is 200 pfu/ml. 277	  
 278	  
Figure 3. The benefit of CRISPR immunity increases with increasing spacer 279	  
diversity.  280	  
Relative fitness of bacterial populations with CRISPR-mediated immunity, with 281	  
spacer diversity as indicated, at 3 days post-infection when competing with a surface 282	  
mutant. Error bars indicate 95% confidence intervals. In all cases, the number of 283	  
biological replicates equals the n values given in the legend of Fig. 2. 284	  
 285	  
Figure 4. Evolution of virus infectivity is constrained by spacer diversity.  286	  
Emergence of virus that overcomes host CRISPR immunity (escape virus) during the 287	  
experiment shown in Figures 2 (panels A-E correspond to Figure 2 A-E). Table 288	  
columns correspond to time points where virus was isolated (0, 16, 24, 40, 48, 64 and 289	  
72 hours post-infection; indicated below the table in days post-infection). Green: no 290	  
escape virus. Red: escape virus. Bold numbers indicate individual biological 291	  
replicates, as detailed in the legend of Figure 2. In B-E replicates are separated by 292	  
bold lines in the table. Numbers between parentheses refer to the clones in the 293	  
CRISPR population. Asterisks indicate virus extinction. 294	  
 295	  
Methods 296	  
Bacterial strains and viruses 297	  
P. aeruginosa UCBPP-PA14 (WT), P. aeruginosa UCBPP-PA14 csy3::LacZ 298	  
(referred to as CRISPR KO, which carries a disruption of an essential cas gene and 299	  
can therefore not evolve CRISPR immunity), the CRISPR KO-derived surface mutant 300	  
and virus DMS3vir have all been described in ref. 6 and references therein. Phage 301	  
DMS3vir+acrF1, which carries the anti-CRISPR gene acrF1 (formerly 30-35), was 302	  
made by inserting acrF1 into the DMS3vir genome using methods described in ref. 7. 303	  
Streptococcus thermophilus strain DGCC7710 and its virus 2972 have been described 304	  
in ref. 2. 305	  
 306	  
Coevolution experiments 307	  
The coevolution experiments shown in Fig. 1 were performed in glass microcosms by 308	  
inoculating 6 ml M9 supplemented with 0.2% glucose with approximately 106 colony 309	  
forming units (cfu) bacteria from fresh overnight cultures of the WT P. aeruginosa 310	  
UCBPP-PA14 or CRISPR KO strain and adding 104 plaque forming units (pfu) of 311	  
virus DMS3vir, followed by incubation at 37 ºC while shaking at 180 rpm (6 312	  
replicates). Cultures were transferred daily 1:100 to fresh broth. Virus titers were 313	  
determined at 0, 3, 5, 11, 17, 22 and 30 days after the start of the coevolution 314	  
experiment by spotting virus samples isolated by chloroform extraction on a lawn of 315	  
CRISPR KO bacteria. The analysis of virus immunity was performed by cross-streak 316	  
assay and PCR as described previously6.  317	  
 318	  
Generation of populations with different levels of CRISPR diversity 319	  
For the competition experiments, shown in Figs. 2-4 and Extended Data Figs. 1B-J 320	  
and Extended Data Figs. 3-4, we generated P. aeruginosa populations with varying 321	  
levels of CRISPR spacer (allele) diversity. To this end, we isolated from the 6 322	  
replicates of the coevolution experiment (Fig. 1) a total of 48 individual clones that 323	  
had acquired CRISPR immunity against virus DMS3vir. We have previously shown 324	  
that individual clones tend to have unique spacers6. Using these 48 clones, 325	  
populations with five different levels of CRISPR spacer (allele) diversity were 326	  
generated. These populations consisted of: 1) 1 clone (a monoculture; a clonal 327	  
population carrying a single spacer); equal mixtures of 2) 6 clones; 3) 12 clones; 4) 24 328	  
clones and 5) 48 clones. In total 48 different monocultures (48 x monocultures), 8 x 6-329	  
clone populations, 4 x 12-clone populations, 2 x 24-clone populations and 1 x 48-330	  
clone population were generated (details of the composition of each population can be 331	  
found below, under “number of replicate experiments”).  332	  
 333	  
Competition experiments 334	  
Competition experiments were done in glass microcosms in a total volume of 6 ml 335	  
M9 supplemented with 0.2% glucose. Competition experiments were initiated by 336	  
inoculating 1:100 from a 1:1 mixture (in M9 salts) of overnight cultures of the 337	  
appropriate CRISPR population and either the surface mutant (Figs. 2-4 and Extended 338	  
Data Figs. 1B-J) or the CRISPR KO strain (Extended Data Figs. 3-4). At the start of 339	  
each experiment 109 pfu of virus was added, unless indicated otherwise. Cultures 340	  
were transferred daily 1:100 into fresh broth. At 0 and 72 hours post-infection (hpi) 341	  
samples were taken and cells were serially diluted in M9 salts and plated on LB agar 342	  
supplemented with 50 µg.ml-1 X-gal (to allow discrimination between WT-derived 343	  
CRISPR clones (white) and CRISPR KO or surface mutant (blue)). The relative 344	  
frequencies of the WT strain were used to calculate the relative fitness (rel. fitness = 345	  
[(fraction strain A at t=x) * (1 – (fraction strain A at t=0))] / [(fraction strain A at t=0) 346	  
* (1 – (fraction strain A at t=x)]). At 0, 16, 24, 40, 48, 66 and 72 hpi, samples were 347	  
taken and chloroform extractions were performed to isolate total virus, which was 348	  
spotted on a lawn of CRISPR KO bacteria for quantification. All subsequent 349	  
statistical analyses were carried out using JMP (v12) software. 350	  
 351	  
Determination of escape virus emergence 352	  
To determine the emergence of escape virus during the competition experiments, 353	  
every isolated virus sample was spotted onto 48 different bacterial lawns, 354	  
corresponding to each of the different CRISPR clones. This procedure was done for 355	  
each of the seven time points (see above), to enable us to track the emergence of 356	  
escape virus against every individual clone over the time course of the experiment.  357	  
 358	  
Deep sequencing 359	  
Isolated phage samples from t=1 dpi of the competition experiment shown in Fig. 2-4 360	  
were used to perform deep sequencing of spacer target sites on the phage genomes. 361	  
To obtain sufficient material, phage were amplified by plaque assay on the CRISPR 362	  
KO strain. Viruses from all replicates within a single diversity treatment were pooled. 363	  
As a control, ancestral virus and escape virus from competition between sm and 364	  
monocultures of CRISPR clones 1-3 were processed in parallel. Virus genomic DNA 365	  
extraction was performed from 5 ml sample at approximately 1010 pfu/ml using the 366	  
Norgen phage DNA isolation kit, following the manufacturer’s instructions. Barcoded 367	  
Illumina Truseq Nano libraries were constructed from each DNA sample with an 368	  
approximately 350bp insert size and 2x 250bp reads generated on an Illumina MiSeq 369	  
platform. Reads were trimmed using Cutadapt v1.2.1 and Sickle v1.200 and then 370	  
overlapping reads merged using Flash v1.2.8 to create high quality sequence at 371	  
approximately 8000x coverage of DMS3vir per sample. These reads were mapped to 372	  
PA14 and DMS3vir genomes using bwa mem v0.7.12 and allele frequencies of SNPs 373	  
within viral target regions quantified using samtools mpileup v0.1.18. Further 374	  
statistical analyses was performed in R v3.2.2. Sequence data are available from the 375	  
European Nucleotide Archive under accession PRJEB12001 and analysis scripts are 376	  
available from https://github.com/scottishwormboy/vanHoute. 377	  
 378	  
Determining the acquisition of new spacers 379	  
To examine spacer acquisition during the competition experiments shown in Fig. 2-4, 380	  
we examined by PCR for each diversity treatment the spacer content of 384 randomly 381	  
isolated clones at both t=0 and t=3 (192 clones per time point). For each replicate 382	  
experiment, the difference in the total number of spacers between t=0 and t=3 was 383	  
divided by the number of clones that were examined to calculate the average change 384	  
in the number of spacers per clone. 385	  
 386	  
Number of replicate experiments 387	  
To ensure equal representation of each of the 48 clones across the different 388	  
treatments, the number of replicate experiments for a given diversity treatment was 389	  
adjusted accordingly, with a total number of replicates of at least 6 for sufficient 390	  
statistical power. Hence, competition experiments with the 1-clone (monoculture) 391	  
populations were performed in 48 independent replicates, each corresponding to a 392	  
unique monoculture of a CRISPR clone (clones 1-48; each clone is equally 393	  
represented). Competition experiments with the 6-clone populations were performed 394	  
in eight independent replicates, each corresponding to a unique polyculture population 395	  
(population 1: equal mixture of clones 1-6; population 2: clones 7-12; population 3: 396	  
clones 13-18; population 4: clones 19-24; population 5: clones 25-30; population 6: 397	  
clones 31-36; population 7: clones 37-42; population 8: clones 43-48). Competition 398	  
experiments with the 12-clone populations were also performed in eight replicates, 399	  
corresponding to 4 unique polyculture populations (replicate 1 and 2: clones 1-12; 400	  
replicate 3 and 4: clones 13-24; replicate 5 and 6: clones 25-36; replicate 7 and 8: 401	  
clones 37-48). Competition experiments with the 24-clone populations were 402	  
performed in six replicates, corresponding to 2 unique polyculture populations 403	  
(replicate 1-3: clones 1-24; replicate 4-6: clones 25-48). Competition experiments 404	  
with the 48-clone populations were performed in six replicates, each corresponding to 405	  
the same polyculture population (replicate 1-6: clones 1-48).  406	  
 407	  
Escape phage degradation and fitness 408	  
In the experiment shown in Extended Data Fig. 1EF, approximately 108 pfus of either 409	  
ancestral virus or escape virus, which was isolated from the competitions between 410	  
monocultures 1-6 and the surface mutant, was used to infect a monoculture of the 411	  
corresponding CRISPR clone or the 48-clone polyculture. Phage samples were taken 412	  
at 0, 9, 20 and 28 hpi by chloroform extraction and titrated on a lawn of the CRISPR 413	  
KO strain. Fitness of each of the escape phages was determined by a competition 414	  
experiment between ancestral and escape virus; a 50:50 ratio of escape and ancestral 415	  
phage (109 pfus total) was used to infect either a monoculture of the corresponding 416	  
CRISPR clone or the 48-clone polyculture. Virus samples were taken at t=0 and t=20 417	  
hpi by chloroform extraction and used in a plaque assay on CRISPR KO. Next, 418	  
individual plaques (48 plaques per replicate) were isolated and amplified on the 419	  
CRISPR KO strain. To determine the ratio of escape and ancestral virus, virus from 420	  
each individual plaque was spotted on a lawn of 1) CRISPR KO (both ancestral and 421	  
escape virus form plaques) and 2) the corresponding CRISPR immune clone (only 422	  
escape virus can form a plaque).  423	  
 424	  
Effect of spacer diversity in Streptococcus thermophilus  425	  
Streptococcus thermophilus DGCC7710 was grown in M17 medium supplemented 426	  
with 0.5% α-lactose (LM17) at 42°C. Virus 2972 was used throughout the 427	  
experiments. Virus infections were carried out using 106 pfus of phage 2972 and 428	  
10mM CaCl2 to facilitate the infection process. To obtain virus-resistant S. 429	  
thermophilus clones, a sample of virus lysate at 24 hpi was plated on LM17 agar 430	  
plates. Individual colonies were picked and PCR-screened for the acquisition of novel 431	  
spacers in each of the 4 CRISPR loci, as described in ref. 2. A total of 44 individual 432	  
clones with a novel spacer in CRISPR1 (see ref. 16 and references therein) were 433	  
selected to generate 44 monocultures and a single polyculture comprised of a mix of 434	  
44 clones. These cultures were infected with 107 pfu of virus, and samples were taken 435	  
after the indicated periods of time to isolate virus. We determined virus titers by 436	  
spotting viral dilutions on lawns of ancestral bacteria, and the emergence of escape 437	  
virus by spotting virus on lawns corresponding to each of the 44 CRISPR resistant 438	  
clones. 439	  
 440	  
Extended Data Table 1. Tukey HSD of all pairwise comparisons of the data in 441	  
Figure 3. 1 = monoculture, 6 = 6-clone polyculture, 12 = 12-clone polyculture, 24 = 442	  
24-clone polyculture, 48 = 48-clone polyculture. 443	  
 444	  
Extended Data Figure 1. CRISPR diversity drives virus extinct since virus 445	  
cannot escape by point mutation. A) Percentage bacteria (WT or CRISPR KO) from 446	  
the experiment shown in Figure 1 that have evolved CRISPR immunity (white bar), 447	  
surface immunity (black bar) or remained sensitive (sensitive; grey bars) at 5 days 448	  
post-infection with virus DMS3vir (n=6 for both treatments). B) Relative fitness of 449	  
CRISPR immune monocultures (single spacer; low diversity, n=48) and polycultures 450	  
(48 spacers; high diversity, n=6) at 3 days post-infection when competing with a 451	  
surface mutant (sm) in the absence of virus. C and D) Deep sequencing analysis of 452	  
the frequency of mutations seed region and PAM of the target sequence of virus 453	  
isolated at t=1 from the experiment shown in Fig. 4. C) Frequency of point mutation 454	  
in the target sequence of viral populations isolated from monoculture 1-3 x sm 455	  
competitions. D) Average frequency of point mutation across all target sites in the 456	  
ancestral virus genome and in the genomes of virus from pooled samples of all 457	  
biological replicates from a single diversity treatment (monocultures: n=48; 6-clone: 458	  
n=8; 12-clone: n=8; 24-clone: n=6; 48-clone: n=6). E and F) Virus that escapes a 459	  
single spacer present in a diverse CRISPR population decreases in frequency, despite 460	  
a fitness benefit over ancestral virus. E) Titers (pfu/ml) over time upon infection of 461	  
monocultures (dotted line) or polycultures of 48 clones (solid line) with 462	  
approximately 108 pfu ancestral (closed circles) or escape (open circles) virus. Escape 463	  
virus was isolated from monocultures 1-6 x sm competitions shown in Fig. 2-4, at 24 464	  
hpi. N=6 for all experiments. The limit of detection is 200 pfu/ml. F) Relative fitness 465	  
of escape virus at t=1 dpi when competing with ancestral virus on CRISPR resistant 466	  
monocultures or polycultures consisting of 48 clones. N=6 for both experiments. G) 467	  
For each diversity treatment shown in Figures 2-4 we examined the spacer content of 468	  
192 randomly isolated clones at both t=0 and t=3 (384 clones in total per diversity 469	  
treatment). The change in the total number of spacers between t=0 and t=3 was 470	  
calculated independently for each replicate experiment (number of biological 471	  
replicates as indicated in legend of Fig. 2) and divided by the number of clones that 472	  
were examined. The graph indicates the average across the replicates of the change in 473	  
spacer content per clone. H, I and J) Titers (pfu/ml) over time of virus carrying an 474	  
anti-CRISPR gene (DMS3vir+acrF1) following infection of a bacterial population 475	  
consisting of an equal mixture of a surface mutant and H) a monoculture with 476	  
CRISPR-mediated immunity (n=48) or I) a 48-clone polyculture with CRISPR-477	  
mediated immunity (n=6). Each clone is equally represented in each treatment. Each 478	  
line indicates a biological replicate experiment. The limit of detection is 200 pfu/ml. 479	  
J) The number of replicate experiments in which the CRISPR immune population 480	  
went extinct (no detectable white colonies) at 1 and 3 dpi. In all cases n is the number 481	  
of biological replicates and error bars indicate 95% CI. 482	  
 483	  
Extended Data Figure 2. Virus persistence inversely correlates with the level of 484	  
CRISPR spacer diversity in CRISPR immune populations of Streptococcus 485	  
thermophilus. Virus titers (pfu/ml) over time upon infection of a bacterial population 486	  
consisting of A) a monoculture with CRISPR-mediated immunity (n=44 biological 487	  
replicates) or B) 44-clone polycultures with CRISPR-mediated immunity (n=28 488	  
biological replicates). Each clone is equally represented in each treatment. Each line 489	  
indicates a biological replicate experiment. The limit of detection is 200 pfu/ml. C) 490	  
OD600 of monocultures and polycultures at 1 and 2 days post infection. Error bars 491	  
indicate 95% confidence intervals. D) Emergence of virus mutants that overcome 492	  
CRISPR-mediated immunity after 0, 16, 24, 40 and 48 hours post-infection. Green 493	  
indicates no escape virus. Red indicates emergence of escape virus. Escape virus 494	  
emerged in none of the polyculture experiments. 495	  
 496	  
Extended Data Figure 3. Sensitive bacteria are unable to invade bacterial 497	  
populations with CRISPR-mediated immunity in the presence of virus. Virus 498	  
titers (pfu/ml) over time upon infection of a bacterial population consisting of an 499	  
equal mixture of a sensitive CRISPR KO clone and A) a monoculture with CRISPR-500	  
mediated immunity (n=48), or polycultures with CRISPR-mediated immunity 501	  
consisting of B) 6 clones (n=8), C) 12 clones (n=8), D) 24 clones (n=6), E) 48 clones 502	  
(n=6). The number of replicates is chosen such that all clones are equally represented 503	  
in each treatment. Each line indicates a biological replicate experiment. The limit of 504	  
detection is 200 pfu/ml. F) Relative fitness of CRISPR populations at 3 days post-505	  
infection during the competitions with the sensitive CRISPR KO described in A-E. 506	  
Relative fitness of CRISPR populations decreases with increasing spacer diversity due 507	  
to the rapid virus extinction, which benefits sensitive bacteria, but is higher than 1 in 508	  
all cases. Error bars indicate 95% CI. G) Relative fitness of monoculture (single 509	  
spacer; low diversity, n=48) and polyculture (48 spacers; high diversity, n=6) at 3 510	  
days post-infection when competing with the CRISPR KO strain in the absence of 511	  
virus. Error bars indicate 95% CI. In all cases n is the number of biological replicates. 512	  
 513	  
Extended Data Figure 4. Evolution of virus infectivity is constrained by CRISPR 514	  
diversity when CRISPR immune populations compete with sensitive CRISPR 515	  
KO bacteria. Emergence of virus mutants that overcome CRISPR-mediated 516	  
immunity during the experiment shown in Extended Data Figure 3. Each column in a 517	  
table represents a time point (0, 16, 24, 40, 48, 64 and 72 hours post-infection, as 518	  
indicated below the table (in days post-infection)) where virus was isolated. Green 519	  
indicates no escape virus. Red indicates emergence of escape virus. Panels A-E 520	  
correspond to each of the experiments shown in Extended Data Figure 3 A-E. Bold 521	  
numbers indicate each of the individual biological replicates, as detailed in the legend 522	  
of Extended Data Fig. 3. In B-E individual replicates are separated by bold lines. 523	  
Numbers between parentheses indicate the identity of clones that are present in a 524	  
population with CRISPR-mediated immunity. Asterisks indicate replicate experiments 525	  
where virus went extinct during the experiment. 526	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